News & Events

News

June 3, 2020

AlivaMab Discovery Services (ADS) Announces Agreement with Tanabe Research Laboratories USA

ADS announces integrated antibody drug discovery collaboration SAN DIEGO, Calif. – June 3, 2020 – AlivaMab Discovery Services, LLC, a ...
CONTINUE READING

May 20, 2020

AlivaMab Discovery Services Announces Planned Leadership Transition

Article Highlights Larry Green, PhD transitions from chief executive officer (CEO) to chairman, board of directors Justin Mika to succeed ...
CONTINUE READING

April 22, 2020

Ablexis, AlivaMab Discovery Services, and Berkeley Lights Collaborate to Identify a Diverse Panel of Anti-SARS-CoV-2 Human Antibodies

Offers unique resources for COVID-19 therapeutic discovery SAN DIEGO and EMERYVILLE, Calif. – April 22, 2020 – Ablexis, LLC, AlivaMab ...
CONTINUE READING

September 16, 2019

AlivaMab Discovery Services Announces Multi-Target Agreement with Janssen

ADS to provide expertise and capabilities in antibody drug discovery SAN DIEGO, Calif. – September 16, 2019 – AlivaMab Discovery ...
CONTINUE READING

February 26, 2019

AlivaMab Discovery Services Identifies Highly Potent Antibodies in Two Months for Inaugural Client Project

Company Expands Team with Veterans of Antibody Discovery and Development SAN DIEGO, Calif. – February 26, 2019 – AlivaMab ...
CONTINUE READING

Case Studies

From Novel Assay Development to Quality Therapeutic Leads on a Rapid Timeline

Webinars

Begin with the End in Mind:

Selection of an Antibody Discovery Platform

How the choice of therapeutic antibody discovery platform can impact downstream success in development and the market.

WATCH

Interviews

Nature speaks to Larry Green, Founder and Chairman of the Board

Harnessing platform technology and expertise to fuel antibody drug discovery

DOWNLOAD

Pharmaceutical Executive speaks with Larry Green

From Mouse to Mab

READ